BA
IDXG

Ballew Advisors’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

Ballew Advisors’s Portfolio IDXG Stock Details IDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,200
Closed -$11K – 528
2018
Q2 		$11K Buy
+1,200
New +$11K 0.01% 298